MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Molecular Pharmacology Fast Forward
First published on July 25, 2006; DOI: 10.1124/mol.106.026815


0026-895X/06/7004-1255-1263$20.00
Mol Pharmacol 70:1255-1263, 2006

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
mol.106.026815v1
70/4/1255    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shimomura, M.
Right arrow Articles by Matsuda, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shimomura, M.
Right arrow Articles by Matsuda, K.

Role in the Selectivity of Neonicotinoids of Insect-Specific Basic Residues in Loop D of the Nicotinic Acetylcholine Receptor Agonist Binding Site

Masaru Shimomura, Maiko Yokota, Makoto Ihara, Miki Akamatsu, David B. Sattelle, and Kazuhiko Matsuda

Department of Applied Biological Chemistry, School of Agriculture, Kinki University, Nara, Japan (M.S., M.Y., M.I., K.M.); Graduate School of Agriculture, Kyoto University, Kyoto, Japan (M.A.); MRC Functional Genetics Unit, Department of Physiology, Anatomy and Genetics, Le Gros Clark Building, University of Oxford, Oxford, United Kingdom (D.B.S.)

The insecticide imidacloprid and structurally related neonicotinoids act selectively on insect nicotinic acetylcholine receptors (nAChRs). To investigate the mechanism of neonicotinoid selectivity, we have examined the effects of mutations to basic amino acid residues in loop D of the nAChR acetylcholine (ACh) binding site on the interactions with imidacloprid. The receptors investigated are the recombinant chicken {alpha}4β2 nAChR and Drosophila melanogaster D{alpha}2/chicken β2 hybrid nAChR expressed in Xenopus laevis oocytes. Although mutations of Thr77 in loop D of the β2 subunit resulted in a barely detectable effect on the imidacloprid concentration-response curve for the {alpha}4β2 nAChR, T77R;E79V double mutations shifted the curve dramatically to higher affinity binding of imidacloprid. Likewise, T77K;E79R and T77N;E79R double mutations in the D{alpha}2β2 nAChR also resulted in a shift to a higher affinity for imidacloprid, which exceeded that observed for a single mutation of Thr77 to basic residues. By contrast, these double mutations scarcely influenced the ACh concentration-response curve, suggesting selective interactions with imidacloprid of the newly introduced basic residues. Computational, homology models of the agonist binding domain of the wild-type and mutant {alpha}4β2 and D{alpha}2β2 nAChRs with imidacloprid bound were generated based on the crystal structures of acetylcholine binding proteins of Lymnaea stagnalis and Aplysia californica. The models indicate that the nitro group of imidacloprid interacts directly with the introduced basic residues at position 77, whereas those at position 79 either prevent or permit such interactions depending on their electrostatic properties, thereby explaining the observed functional changes resulting from site-directed mutagenesis.


Received May 18, 2006; accepted July 25, 2006

Address correspondence to: Kazuhiko Matsuda PhD, Department of Applied Biological Chemistry, School of Agriculture, Kinki University, 3327-204 Nakamachi, Nara 631-8505, Japan. Email: kmatsuda{at}nara.kindai.ac.jp




This article has been cited by other articles:


Home page
Mol. Pharmacol.Home page
K. Matsuda, S. Kanaoka, M. Akamatsu, and D. B. Sattelle
Diverse Actions and Target-Site Selectivity of Neonicotinoids: Structural Insights
Mol. Pharmacol., July 1, 2009; 76(1): 1 - 10.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
S. Amiri, M. Shimomura, R. Vijayan, H. Nishiwaki, M. Akamatsu, K. Matsuda, A. K. Jones, M. S. P. Sansom, P. C. Biggin, and D. B. Sattelle
A Role for Leu118 of Loop E in Agonist Binding to the {alpha}7 Nicotinic Acetylcholine Receptor
Mol. Pharmacol., June 1, 2008; 73(6): 1659 - 1667.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
M. Tomizawa, D. Maltby, T. T. Talley, K. A. Durkin, K. F. Medzihradszky, A. L. Burlingame, P. Taylor, and J. E. Casida
Atypical nicotinic agonist bound conformations conferring subtype selectivity
PNAS, February 5, 2008; 105(5): 1728 - 1732.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
M. Tomizawa, T. T. Talley, D. Maltby, K. A. Durkin, K. F. Medzihradszky, A. L. Burlingame, P. Taylor, and J. E. Casida
Mapping the elusive neonicotinoid binding site
PNAS, May 22, 2007; 104(21): 9075 - 9080.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2006 by the American Society for Pharmacology and Experimental Therapeutics